NOVACINA

Serial Number 97759722
606

Registration Progress

Application Filed
Jan 18, 2023
Under Examination
Apr 23, 2024
Approved for Publication
Feb 7, 2024
Published for Opposition
Feb 27, 2024
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Jan 24, 2026 25 days
Revival assistance for abandoned trademark

Trademark Image

NOVACINA

Basic Information

Serial Number
97759722
Filing Date
January 18, 2023
Published for Opposition
February 27, 2024
Abandonment Date
November 24, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 24, 2025
Classes
005 040 042

Rights Holder

Bridgewest International Holdings LLC

16
Address
701 Brickell Avenue, Suite 1490
Miami, FL 33131

Ownership History

Bridgewest International Holdings LLC

Original Applicant
16
Miami, FL

Bridgewest International Holdings LLC

Owner at Publication
16
Miami, FL

Legal Representation

Attorney
Lisel M. Ferguson

USPTO Deadlines

Next Deadline
25 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
January 24, 2026

Application History

34 events
Date Code Type Description Documents
Nov 24, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 24, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 16, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 16, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 22, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 14, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 21, 2025 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Jul 21, 2025 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Jul 21, 2025 PETG O PETITION TO REVIVE-GRANTED Loading...
Jul 21, 2025 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Mar 31, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 31, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 31, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 15, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 23, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 23, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 23, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 25, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 25, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 17, 2023 LOPR P LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN Loading...
Oct 16, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 6, 2023 LOPT I LETTER OF PROTEST EVIDENCE FORWARDED Loading...
Jan 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 21, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for use by humans, namely, sterile injectable pharmaceutical preparations for the treatment of dehydration, low potassium levels, bleeding, infection, and pain
Class 040
Custom manufacture of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain
Class 042
Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Classification

International Classes
005 040 042